Two cases of AML-NOS (WHO-HAEM4R) were classified as AML-MR (WHO-HAEM5) and AML-MRC (ICC) because of ASXL1 and SRSF2 mutations and ASXL1 and U2AF1 mutations, respectively. Here, ASXL1 is linked to intrahepatic cholangiocarcinoma.